AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7774443
Drug: Combined operative
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined operative resection and chemotherapy (OC)
Trial: 2328258
Drug: L-carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (2 g)
Trial: 20872758
Drug: Readiness and
RxNorm normalized name: norgestimate and ethinylestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Readiness and Motivation Therapy (RMT)
Trial: 19576320
Drug: Triple antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple antiplatelet regimen (aspirin plus clopidogrel plus cilostazol)
Trial: 19576320
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet regimen (aspirin plus clopidogrel)
Trial: 15374367
Drug: Idebenone 45
RxNorm normalized name: idebenone 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idebenone 45 mg twice daily p.o.
Trial: 15374367
Drug: Oxiracetam 800
RxNorm normalized name: oxiracetam 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxiracetam 800 mg twice daily p.o.
Trial: 31778196
Drug: Single-dose antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose antibiotic therapy
Trial: 30134944
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment with posterior C1-C2 fusion
Trial: 30134944
Drug: Non-surgical treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical treatment with a rigid cervical collar for 12 weeks
Trial: 26970335
Drug: 2.6 g
RxNorm normalized name: SODIUM BICARBONATE 2.6 g in 2.6 g ORAL POWDER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.6 g omega‐3 LCPUFA supplementation
Trial: 26970335
Drug: Placebo of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo of 2.7 g soya bean oil
Trial: 21693549
Drug: Pregabalin 300-600
RxNorm normalized name: pregabalin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 300-600 mg/day
Trial: 15781528
Drug: IV fluid
RxNorm normalized name: IV fluid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV fluid administration
Trial: 15781528
Drug: Fluid types
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid types and administration strategies
Trial: 10682127
Drug: Zalcitabine 0.75
RxNorm normalized name: zalcitabine 0.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zalcitabine 0.75 mg every 8 hours
Trial: 10682127
Drug: Saquinavir 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir 600 mg every 8 hours
Trial: 10682127
Drug: Combination zalcitabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination zalcitabine 0.75 mg plus saquinavir 600 mg every 8 hours
Trial: 1747216
Drug: Quinapril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (5 mg oral twice daily, titrated to 20 mg twice daily)
Trial: 1747216
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg oral twice daily, titrated to 100 mg twice daily)
Trial: 402697
Drug: b.i.d. dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: b.i.d. dosage schedule of 500 mg twice daily
Trial: 402697
Drug: t.i.d. dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: t.i.d. dosage schedule of 250 mg three times daily
Trial: 31708422
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg bolus before incision, followed by 0.5 mg/kg/h infusion until end of surgery)
Trial: 28671307
Drug: Insulin iontophoresis
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin iontophoresis in IS groups (ABIS and SCIS)
Trial: 28671307
Drug: Net insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Net insulin response (NetIns) in IS cohorts (ABIS and SCIS)
Trial: 23439596
Drug: L‐NMMA (NOS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐NMMA (NOS inhibitor)
Trial: 15987284
Drug: Tacalcitol ointment
RxNorm normalized name: tacalcitol
DrugBank: Tacalcitol (DB13689)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacalcitol ointment (4 microg/g) applied once daily for 2 months
Trial: 12962951
Drug: Tolterodine extended
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine extended release 4 mg once daily
Trial: 10543293
Drug: Home i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home i.v. antibiotic treatment (HIVAT, 14 days)
Trial: 10543293
Drug: Inhaled amiloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled amiloride (14 days)
Trial: 713434
Drug: Tinofedrine (0.12‐‐0.17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinofedrine (0.12‐‐0.17 mg/kg bodyweight)
Trial: 24287284
Drug: 1.8 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 g/day esterified plant sterols and stanols
Trial: 20350253
Drug: Xuezhikang (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuezhikang (0.6 g twice daily)
Trial: 15986863
Drug: Partially hydrolyzed
RxNorm normalized name: Human Skin Proteins, Partially Hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially hydrolyzed guar gum (PHGG) 5 g/day
Trial: 12184518
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran 30 g/day
Trial: 15361500
Drug: CDP571 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP571 (10 mg/kg)
Trial: 7788147
Drug: CDP571 (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP571 (1.0 mg/kg)
Trial: 7788147
Drug: CDP571 (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP571 (0.1 mg/kg)
Trial: 2193996
Drug: Informed group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Informed group (received patient education about drug side effects)
Trial: 2193996
Drug: Uninformed group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uninformed group (no information about drug side effects)
Trial: 2193996
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (compliance with therapy)
Trial: 2193996
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (results of treatment)
Trial: 84951
Drug: Antipyrine (phenazone)
RxNorm normalized name: Antipyrine
DrugBank: Antipyrine (DB01435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipyrine (phenazone) treatment of mothers from the 38th week of pregnancy
Trial: 16751162
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine 5 microg/kg
Trial: 11074738
Drug: Androstenedione (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androstenedione (200 mg/d)
Trial: 11074738
Drug: Androstenediol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androstenediol (200 mg/d)
Trial: 8873543
Drug: Simultaneous administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simultaneous administration of desflurane to both lungs
Trial: 8873543
Drug: Topical and
RxNorm normalized name: norgestimate and ethinylestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical and nebulized lidocaine, glossopharyngeal and superior laryngeal nerve blocks, transtracheal administration of lidocaine
Trial: 8873543
Drug: Systemic infusions
RxNorm normalized name: nitroglycerin
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic infusions of 2% lidocaine
Trial: 26746903
Drug: Referral for
RxNorm normalized name: teferrol
DrugBank: Iron polymaltose (DB15763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Referral for a post discharge medicines use review (MUR) with their regular community pharmacist
Trial: 22678319
Drug: Diclofenac 1
RxNorm normalized name: diclofenac 18 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 1 mg/kg
Trial: 22678319
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of diclofenac and ketamine (0.15 mg/kg)
Trial: 22678319
Drug: Placebo (100-mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (100-mL isotonic saline)
Trial: 7838584
Drug: Ketamine (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.15 mg/kg)
Trial: 22678319
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of diclofenac and ketamine
Trial: 21970545
Drug: Rosiglitazone therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone therapy
Trial: 20656674
Drug: Rosiglitazone therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone therapy (excluding RECORD trial)
Trial: 20656674
Drug: Rosiglitazone therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone therapy (alternative analysis)
Trial: 10765125
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of FU (600 mg/m2/week x 6, followed by a 2-week rest) and LV (500 mg/m2/week x 6 as a 2-hour infusion, followed by a 2-week rest) for 4 cycles (group A)
Trial: 10765125
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of FU and LV plus recombinant IFN (3 MU subcutaneously 3 times a week for 1 year) (group B)
Trial: 1994661
Drug: High-dose diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose diltiazem (mean dose, 329 mg/day)
Trial: 8289096
Drug: Comprehensive multidisciplinary
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive multidisciplinary treatment strategy
Trial: 8289096
Drug: Comprehensive multidisciplinary
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive multidisciplinary treatment strategy (in intermediate risk subgroup)
Trial: 3511404
Drug: High-dose parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose parenteral 6-methylprednisolone (MP)
Trial: 29572124
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg baclofen
Trial: 28199679
Drug: DNA/rAd5 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DNA/rAd5 vaccine
Trial: 16586388
Drug: Rifaximin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin (200 mg 3 times daily for 3 days)
Trial: 14959882
Drug: 14 percent
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 14 percent hydrogen peroxide gel strip (Crest Whitestrips Supreme)
Trial: 9187023
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) intravenous (iv)
Trial: 9187023
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) subcutaneous (sc)
Trial: 8387806
Drug: Perindoprilat (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindoprilat (1 mg over six hours)
Trial: 8387806
Drug: Enalaprilat (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalaprilat (1.5 mg over six hours)
Trial: 8387806
Drug: Intravenous placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous placebo (saline)
Trial: 3544631
Drug: nadolol 80
RxNorm normalized name: nadolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nadolol 80 mg/day
Trial: 25854500
Drug: ACL conservative
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACL conservative treatment
Trial: 25033066
Drug: Alendronate (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (40 mg daily for subjects > 50 kg, 20 mg for 30‐50 kg, 10 mg for 20‐30 kg)
Trial: 15875530
Drug: Lycopene (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene (30 mg daily for 1 week)
Trial: 12885710
Drug: Iron-fortified fish
RxNorm normalized name: INFANT FORMULA SMA IRON FORTIFIED CONC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified fish sauce (10 mL containing 10 mg Fe as NaFeEDTA)
Trial: 11143915
Drug: Harpagophytum 2,610
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Harpagophytum 2,610 mg per day
Trial: 11143915
Drug: Diacerhein 100
RxNorm normalized name: diacetylrhein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diacerhein 100 mg per day
Trial: 28723914
Drug: Dalazatide 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalazatide 30 mcg/dose
Trial: 28723914
Drug: Dalazatide 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalazatide 60 mcg/dose
Trial: 26496265
Drug: Pirfenidone (1800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirfenidone (1800 mg per day) + NAC (1800 mg per day)
Trial: 26496265
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + NAC (1800 mg per day)
Trial: 15585770
Drug: Zinc doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc doses of 2.2 mg
Trial: 15585770
Drug: Zinc doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc doses of 5.2 mg
Trial: 15585770
Drug: Zinc doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc doses of 10.4 mg
Trial: 15585770
Drug: Zinc doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc doses of 15.2 mg
Trial: 15585770
Drug: Zinc doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc doses of 20.3 mg
Trial: 15585770
Drug: Zinc doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc doses of 30.1 mg
Trial: 11736882
Drug: UDCA (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA (50 mg)
Trial: 11736882
Drug: CDCA (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDCA (600 mg)
Trial: 11736882
Drug: Control (nitrendipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (nitrendipine 10 mg without bile acids)
Trial: 7835324
Drug: Raw potato
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raw potato starch (RPS) 50 g
Trial: 7835324
Drug: Corn flakes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn flakes (CF) 100 g
Trial: 7835324
Drug: Hylon VII
RxNorm normalized name: factor VII
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hylon VII high amylomaize starch (HAS) 75 g
Trial: 7835324
Drug: Hylon VII
RxNorm normalized name: factor VII
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hylon VII high amylomaize starch (HRA) 25 g
Trial: 7835324
Drug: Daily administration
RxNorm normalized name: Prevpac 30mg-500mg-500mg Daily Administration Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily administration of RPS for 3 weeks
Trial: 7835324
Drug: Daily administration
RxNorm normalized name: Prevpac 30mg-500mg-500mg Daily Administration Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily administration of HAS for 3 weeks
Trial: 2964327
Drug: Miglitol 50mg
RxNorm normalized name: MIGLITOL 50MG TAB
DrugBank: Miglitol (DB00491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Miglitol 50mg three times daily for 4 weeks
Trial: 19675034
Drug: Steroid injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid injection (group B)
Trial: 16311070
Drug: Serum digoxin
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Serum digoxin concentration (SDC) ≥1.2 ng/ml
Trial: 16311070
Drug: Serum digoxin
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Serum digoxin concentration (SDC) 0.5-1.1 ng/ml
Trial: 16311070
Drug: Serum digoxin
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Serum digoxin concentration (SDC) 0.5-1.1 ng/ml in women with EF <35%
Trial: 16311070
Drug: Serum digoxin
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Serum digoxin concentration (SDC) 0.5-1.1 ng/ml in women with EF ≥35%
Trial: 15309451
Drug: Lycopene tablets
RxNorm normalized name: lycopene Oral Tablet
DrugBank: Lycopene (DB11231)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lycopene tablets
Trial: 11576930
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with supraphysiological doses of folic acid and vitamins B(6) and B(12)
Trial: 9244210
Drug: Low-dose ramipril
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ramipril (0.625 mg daily)
Trial: 9244210
Drug: Full-dose ramipril
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full-dose ramipril (1.25 mg titrated to 10 mg/d)
Trial: 2244446
Drug: Cimetidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (200 mg IV)
Trial: 2244446
Drug: Famotidine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine (20 mg IV)
Trial: 30058959
Drug: Rivaroxaban 2.5
RxNorm normalized name: rivaroxaban 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 2.5 mg bid plus acetylsalicylic acid 100 mg
Trial: 30058959
Drug: Rivaroxaban 5
RxNorm normalized name: Rivaroxaban
DrugBank: Rivaroxaban (DB06228)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rivaroxaban 5 mg bid
Trial: 30058959
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid 100 mg per day
Trial: 28422300
Drug: Atorvastatin LD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin LD 80 mg
Trial: 28422300
Drug: Rosuvastatin LD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin LD 40 mg
Trial: 28422300
Drug: Low-dose statins
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose statins (subgroup analysis)
Trial: 26224613
Drug: Autologous conditioned
RxNorm normalized name: AUTOLOGOUS CONDITIONED PLASMA
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous conditioned plasma (ACP) injections
Trial: 23289345
Drug: JCS‐01 focused
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JCS‐01 focused ultrasound fat reduction machine treatment on the 1st and 7th days.
Trial: 23289345
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with ultrasound energy turned off during treatments.
Trial: 16256784
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment during cardiopulmonary bypass
Trial: 10218737
Drug: Mibefradil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mibefradil (50 mg, titrated to 100 mg)
Trial: 10218737
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 mg, titrated to 2 x 20 mg)
Trial: 8730975
Drug: Allopurinol 100
RxNorm normalized name: allopurinol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol 100 mg
Trial: 28608311
Drug: Allopurinol 600
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol 600 mg
Trial: 8730975
Drug: Allopurinol 900
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol 900 mg
Trial: 1858727
Drug: H influenzae
RxNorm normalized name: h influenzae type b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H influenzae b oligosaccharide‐CRM197 conjugate vaccine (3 doses)
Trial: 1858727
Drug: H influenzae
RxNorm normalized name: h influenzae type b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H influenzae b oligosaccharide‐CRM197 conjugate vaccine (2 doses) followed by H influenzae type b polysaccharide vaccine (1 dose)
Trial: 1858727
Drug: H influenzae
RxNorm normalized name: h influenzae type b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H influenzae b oligosaccharide‐CRM197 conjugate vaccine (1 dose) followed by H influenzae type b polysaccharide vaccine (2 doses)
Trial: 1858727
Drug: H influenzae
RxNorm normalized name: h influenzae type b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H influenzae type b polysaccharide vaccine (as a second dose)
Trial: 30794252
Drug: Microtextured implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microtextured implants with microgrooved collar design
Trial: 30794252
Drug: Narrow implant
RxNorm normalized name: YARROW
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrow implant diameter
Trial: 25393645
Drug: Abaloparatide 20
RxNorm normalized name: Abaloparatide 2000 MCG/1 ML Subcutaneous Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abaloparatide 20 μg
Trial: 25393645
Drug: Abaloparatide 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abaloparatide 40 μg
Trial: 25393645
Drug: Teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide 20 μg
Trial: 3914885
Drug: Intravaginal PGF2
RxNorm normalized name: Intravaginal contraceptives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal PGF2 alpha (40 mg in tylose gel)